Tied up in red tape

A change in Spain’s credit derivatives law is expected to open the floodgates to a number of synthetic securitisations. But scepticism about the credit default swap market on the part of the country’s financial regulators is likely to make change a slow process, reports Hardeep Dhillon

spain-carreno-gif

Spanish banks, like their peers elsewhere in Europe, are looking to use credit default swaps (CDSs) to transfer risk off the balance sheet and offer investors new products. But Spain’s financial regulators have been far from accommodating.

Perhaps the best example of this is in the synthetic securitisation market, where credit derivatives are used to package up risk and sell it on to investors as a securitised transaction. There have so far been two such deals in Spain but both were limited to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here